REPORT HIGHLIGHT
The Biomaterials Market size was valued at USD 154,068.9 Million in 2022, expanding at a CAGR of 13.9% from 2023 to 2030.
Biomaterials are nonviable materials that can be utilized to replace or repair human tissues and organs. It can be derived from nature or created in a laboratory. They are frequently utilized in medical applications to support, augment, or replace damaged tissue or biological functions. These materials can be of any sort, so long as they are compatible with the human body and can be employed for medical purposes. This comprises metals, ceramics, polymers, composites, and, more recently, nanoscale materials. Biomaterials can be created to deliver medications to particular sites within the body, increasing drug delivery efficiency while decreasing side effects.
Biomaterials Market- Market Dynamics:
- The rising prevalence of musculoskeletal and chronic skeletal medical conditions is expected to boost the demand for the biomaterials market.
- As the world population ages, the prevalence of illnesses such as osteoporosis, arthritis, and other musculoskeletal disorders rises. This will increase the demand for biomaterials for bone repair, replacement, or enhancement. According to the World health organization, approximately 1.71 billion people have musculoskeletal conditions worldwide. Musculoskeletal conditions are the leading contributor to disability worldwide, with low back pain being the single leading cause of disability in 160 countries. Rapid advancements in biomaterial technology give a significant opportunity for expansion. Nanotechnology, biotechnology, material science, and tissue engineering advancements can lead to the development of more efficient and effective biomaterials. However, Stringent Regulations may hamper the growth of the biomaterials market.
Biomaterials Market- Key Insights:
- As per the analysis shared by our research analyst, the global Biomaterials market is estimated to grow annually at a CAGR of around 13.9% over the forecast period (2023-2030)
- The Biomaterials industry is projected to grow at a significant rate due to the growing awareness of sustainable growth
- Based on Product type segmentation, Polymers was predicted to show maximum market share in the year 2022
- Based on Application segmentation, Orthopedic was the leading type in 2022
- On the basis of region, North America was the leading revenue generator in 2022
Biomaterials Market- Segmentation Analysis:
- The Global Biomaterials Market is segmented on the basis of Product Type, Application, and Region.
- The market is divided into three categories based on product type: Metallic, Natural, Ceramics, and Polymers. Polymers dominate the market. Polymers account for a sizable portion of the biomaterials market due to their various characteristics and customizability. They are frequently employed in a variety of medical applications, including medication delivery systems, implants, sutures, and contact lenses.
- The market is divided into two categories based on application: Cardiovascular, Ophthalmology., Dental, Orthopedic, Wound healing, Tissue engineering, Neurology, and others. The Orthopedic sector dominates the market and is likely to maintain its dominance during the forecast period. Metals, ceramics, polymers, and composites, as well as biomaterials, have been utilized in orthopedics for a variety of applications, including joint replacements, bone fixations, and spinal fusions.
Biomaterials Market- Geographical Insights:
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is anticipated to dominate the market growth, due to a rise in funding by the government to increase R&D activities in the field of biomaterials. North America continually sees significant public and private sector investment in healthcare R&D, including biomaterials. The National Institutes of Health (NIH), the National Science Foundation (NSF), and other government entities offer major financing for medical research, including biomaterial creation and use. United States (U.S.) medical and health research and development (R&D) investment reached USD245.1 billion in 2020, an 11.1% increase from 2019. The 2020 estimates suggest changes in growth rates across the public-private sector R&D ecosystem, but it is likely these changes predominantly reflect the response to, and impact of, the COVID-19 pandemic. Europe is another leading region for the growth of the market in the forecast period, owing to an increase in awareness about the advantages of biomaterials products.
Biomaterials Market- Competitive Landscape:
A number of factors contributed to the increase in demand for biomaterials. The rising frequency of chronic diseases, the aging global population, and growing awareness of the benefits of biomaterial-based medicinal goods are all driving up demand. The biomaterials industry is highly competitive, with numerous large worldwide competitors as well as a number of new players. The manufacturers compete based on factors such as the performance characteristics of their biomaterials, price, innovation, and their relationships with healthcare providers. For Example, on June 29, 2023, Modern Meadow, a purpose-driven biotechnology company, is proud to announce its strategic partnership with BASF, a leading global chemical company, to embark on a collaboration to revolutionize the material industry.
Recent Developments:
On April 21, 2021, Medtronic plc, the global leader in medical technology, nowadays announced it received approval from the United States Food and Drug Administration (FDA) for Pipeline Flex Embolization Device with Shield Technology. Medtronic developed Shield Technology, a proprietary breakthrough in biomaterial science, to advance flow diversion therapy by introducing the first surface-modified implant device which demonstrates a reduction in material thrombogenicity, a reduction in the tendency of the surface treatment material to create clots.
Key features of the study:
- This proposed research study on Biomaterials market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
- The report provides the client the latest up-to-date and trending insights about the Biomaterials market.
- The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Biomaterials market
- The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Biomaterials market
- Impact of COVID-19 on Biomaterials market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Biomaterials market post-COVID will also be covered.
- In order to give the users of this report a comprehensive view on the Biomaterials market, we have also included competitive landscape and key innovator analysis for the Biomaterials market.
- The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
- The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Biomaterials market.
- In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
- The global Biomaterials market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL BIOMATERIALS MARKET KEY PLAYERS
- Johnson & Johnson
- Dentsply Sirona
- CoorsTek Inc.
- Corbion
- Collagen Matrix, Inc.
- Medtronic plc
- Evonik Industries AG
- Carpenter Technology Corporation
- Berkeley Advanced Biomaterials
- Invibio Ltd.
- Zimmer Biomet Holdings, Inc.
- BASF SE
- Covalon Technologies Ltd.
- Stryker
GLOBAL BIOMATERIALS MARKET, BY PRODUCT TYPE
- Metallic
- Natural
- Ceramics
- Polymers
GLOBAL BIOMATERIALS MARKET, BY APPLICATION
- Cardiovascular
- Sensors
- Stents
- Guidewires
- Implantable Cardiac Defibrillators
- Pacemakers
- Vascular Grafts
- Others
- Ophthalmology
- Synthetic Corneas
- Intraocular Lens
- Contact Lens
- Ocular Tissue Replacement
- Others
- Dental
- Tissue Regeneration Materials
- Dental Implants
- Bone Grafts & Substitutes
- Dental Membranes
- Others
- Orthopedic
- Joint Replacement Biomaterials
- Orthobiologics
- Bioresorbable Tissue Fixation Products
- Viscosupplementation
- Spine Biomaterials
- Others
- Wound Healing
- Fracture Healing Device
- Adhesion Barrier
- Skin Substitutes
- Internal Tissue Sealant
- Surgical Hemostats
- Others
- Tissue Engineering
- Plastic Surgery
- Facial Wrinkle Treatment
- Soft Tissue Fillers
- Craniofacial Surgery
- Bioengineered Skins
- Peripheral Nerve Repair
- Acellular Dermal Matrices
- Others
- Neurology
- Neural Stem Cell Encapsulation
- Shunting Systems
- Hydrogel Scaffold For CNS Repair
- Cortical Neural Prosthetics
- Others
- Others
GLOBAL BIOMATERIALS MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA